15-81333021-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001080532.3(TMC3):āc.2701C>Gā(p.Leu901Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000341 in 1,613,830 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001080532.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMC3 | NM_001080532.3 | c.2701C>G | p.Leu901Val | missense_variant | 22/22 | ENST00000359440.6 | NP_001074001.1 | |
TMC3-AS1 | NR_120365.1 | n.426+480G>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMC3 | ENST00000359440.6 | c.2701C>G | p.Leu901Val | missense_variant | 22/22 | 1 | NM_001080532.3 | ENSP00000352413.5 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152182Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000241 AC: 6AN: 249174Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135168
GnomAD4 exome AF: 0.0000349 AC: 51AN: 1461648Hom.: 0 Cov.: 80 AF XY: 0.0000316 AC XY: 23AN XY: 727102
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152182Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74348
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 01, 2024 | The c.2701C>G (p.L901V) alteration is located in exon 22 (coding exon 22) of the TMC3 gene. This alteration results from a C to G substitution at nucleotide position 2701, causing the leucine (L) at amino acid position 901 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at